Tumor-associated peptides that bind to MHC-molecules
Details for Australian Patent Application No. 2005247598 (hide)
International Classifications
Event Publications
21 December 2006 PCT application entered the National Phase
PCT publication WO2005/116051 Priority application(s): WO2005/116051
28 April 2011 Alteration of Name
The name of the applicant has been altered to immatics biotechnologies GmbH
2 June 2011 Application Accepted
Published as AU-B-2005247598
23 June 2011 Application for Amendment
The nature of the amendment is: Amend the name of the inventor to read Stevanovic, Stefan; Rammensee, Hans-Georg; Weinschenk, Toni and Lemmel, Claudia. Address for service in Australia - Pizzeys Patent and Trade Mark Attorneys Level 20 324 Queen Street Brisbane QLD 4000
13 October 2011 Amendment Made
The nature of the amendment is: Amend the name of the inventor to read Stevanovic, Stefan; Rammensee, Hans-Georg; Weinschenk, Toni and Lemmel, Claudia
20 October 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005247600-Refuse treatment plant
2005247589-2-styryl-4-oxazole-methanol-ethers and their use as tyrosine kinase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser